/fi/alasivut/ajankohtaista/muistisairauksista-maailmanlaajuinen-terveysprioriteetti/

Uusimmat uutiset

Kaikki uutiset

Vertaistukea tarjolla

Tukea muistisairaan läheiselle:

Vertaislinja-tukipuhelin

p. 0800 9 6000

(maksuton, joka päivä klo 17-21)

 

Keskusteluja muistisairaille ja läheisille verkossa:

Vertaislinja-keskustelupalsta

 

Toimintaa ja tukea kaikille

muistiyhdistyksissä

 

Liity jäseneksi

Allekirjoita:

Muistisairauksista maailmanlaajuinen terveysprioriteetti?

Seuraava G20-maiden huippukokous järjestetään marraskuussa Australiassa. Muistisairaudet halutaan lisätä kokouksen asialistalle, kuten ne olivat myös hiljattain pidetyssä G8-maiden huippukokouksessa Iso-Britanniassa. Allekirjoita oheinen vetoomus ja ole mukana vaatimassa, että muistisairaudet todella luetaan maailman terveysprioriteetiksi! Tavoitteena on 20 000 nimeä.

Allekirjoita vetoomus tästä!

GOAL – 20,000 signatures

Let’s make dementia a G20 priority 

Australia will host the next meeting of the Group of Twenty (G20) in November. We ask our Prime Minister, Mr Tony Abbott, to place dementia prominently on the G20 agenda. He will follow the lead of the British Prime Minister who recently hosted the G8 Dementia Summit, and called dementia “the disease that steals lives, wrecks families and beaks hearts” and recognised it as “an increasing threat to global health”.

At the recent G8 summit, the leading economies of the world made a commitment to developing a cure for dementia by 2025. The UK said it would double its annual research funding for dementia to £132m by 2025. The USA has increased its funding for dementia recently by 12.5%. However, all this comes from a low base, with research funding for cancer currently being about 8 times, and for cardiovascular disease about 6 times that for dementia in high income countries (HICs). A huge imbalance will continue to exist.

Of course, dementia is a global problem, currently costing more than $600 billion annually, and growing exponentially. The greatest growth is in low and middle income countries (LMICs). Already, there are more dementia patients in LMICs, and by the middle of the century, more than 70% of dementia patients will be in these countries, which are ill-equipped to deal with the burden of dementia. In many countries, there is a lack of awareness of the problem, dementia is poorly diagnosed and facilities for treatment and care are rudimentary. ADI estimated that 3 out of every 4 of the 36 million people worldwide living with dementia have not been formally diagnosed and are not receiving treatment and care. The “treatment gap” is most significant in developing nations. In Australia, the average delay between the onset of noticeable symptoms and a firm diagnosis is 3.1 years. Putting dementia on the G20 agenda and getting a commitment from the leaders of countries like China, India and Brazil is likely to have a remarkable impact on dementia awareness, care and research around the world.

More funds are needed for the diagnosis, treatment and care of dementia patients. An investment into dementia research is urgently needed from all countries, led by but not restricted to the rich nations. In many parts of the world, research into dementia is non-existent. This, combined with the relative neglect of dementia research in rich countries, has created a major gap between the disability and suffering attributable to dementia and the research investment into its diagnosis, treatment and appropriate care. Greater research funding will help develop new treatments, but more importantly, exploit the current knowledge to develop strategies to prevent dementia or delay its onset. The G8 has set ambitious targets. We ask Mr Abbott to take the lead and make it a truly global fight against the dementia time bomb.

Thank you for your support in this initiative.

CENTRE FOR HEALTHY BRAIN AGEING (CHeBA)

  • Professor Perminder Sachdev (Co-Director)
  • Professor Henry Brodaty (Co-Director)
  • Heidi Mitchell (Marketing & Communications Officer)
Sivu päivitetty 24.1.2014

MUISTILIITTO RY
Pasilanraitio 9 B, 7.krs
00240 Helsinki 

Puhelin 09 6226 200 
Sähköposti toimisto(at)muistiliitto.fi
Tarkemmat yhteystiedot »

Muistiliitto ry on vuonna 1988 perustettu kansanterveys-, potilas- ja omaisjärjestö. Toiminnan tarkoituksena on edistää tämän kohderyhmän elämänlaadun ja hyvinvoinnin yleisiä edellytyksiä. Muistiliitolla on 44 jäsenyhdistystä ympäri Suomen.

Muistiliitto ry rekisteriseloste (pdf)